Sort
261,768 grants matching “gene therapy”
Genetically Engineered Mouse Models to Study Melanoma Genesis and Progression
$1,211,771Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Molecular and Cellular Mechanisms of Experience-Dependent Cortical Processing
$1,211,566Kuan Wang · National Institute Of Mental Health · ZIA · FY2014 · MH
DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs
$1,211,401Yves Pommier · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
HIV Persistence During Suppressive Antiretroviral Therapy
$1,211,385Frank Maldarelli · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
SLEEP, AGING AND CIRCADIAN RHYTHM DISORDERS
$1,211,342Brigham And Women'S Hospital · P01 · FY2002 · AG
Quantitative assessment of pre-metastatic immune subversion as a risk factor for melanoma relapse
$1,211,213Svetomir Nenad Markovic · Mayo Clinic Rochester · R01 · FY2025 · CA
Developing Cone-Dominant Retinal Disease Models as a Resource for Translational Vision Research
$1,211,170Joseph Carroll · Medical College Of Wisconsin · U24 · FY2019 · EY
Effects of the Next Generation TNF Inhibitor (XPro1595) on Inflammation-related Deficits in Reward Circuitry and Motivation in Depression
$1,210,682Christopher J Barnum · Inmune Bio, Inc. · R44 · FY2021 · MH
LyMB Clinical Trials Team
$1,210,652Thomas Waldmann · Division Of Basic Sciences - Nci · ZID · FY2015 · CA
Molecular genetics of MLL-associated leukemia
$1,210,621Manuel O Diaz · Loyola University Chicago · P01 · FY2009 · CA
Rhythmicity and Synchrony in the Basal Ganglia
$1,210,543Dalton James Surmeier · Northwestern University At Chicago · P50 · FY2012 · NS
Integrative Omics as a Discovery Tool for Pulmonary Hypertension
$1,210,211Marlene Rabinovitch · Stanford University · R01 · FY2017 · HL
Antigen Processing And Presentation In The Intestine
$1,210,048Brian Kelsall · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Clinical and translational studies of RUNX1 and FPD
$1,210,025Paul Liu · National Human Genome Research Institute · ZIA · FY2020 · HG
Mechanism, Regulation and Application of miRNA pathway in cancer
$1,210,023Shuo Gu · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
USE OF GENETICALLY MODIFIED SKIN TO TREAT DISEASE
$1,209,926University Of Utah · P01 · FY2003 · HD
Discovery of solubilizing side chains for in vivo release of diverse drug classes using the Click Activated Protodrugs (CAP) platform
$1,209,827Nathan Yee · Tambo, Inc. · R44 · FY2025 · TR
MRI-guided focused ultrasound for drug delivery and ablation of brain tumors
$1,209,609Nathan J McDannold · Brigham And Women'S Hospital · P01 · FY2017 · CA
Expansion of Cardiac and Hematopoietic Pregenitors by Wnt and Notch
$1,209,566Irwin Bernstein · Fred Hutchinson Cancer Research Center · U01 · FY2012 · HL
Expansion of Cardiac and Hematopoietic Pregenitors by Wnt and Notch
$1,209,566Irwin Bernstein · Fred Hutchinson Cancer Research Center · U01 · FY2011 · HL
Preclinical Development of Novel Rickettsiosis Therapeutics Targeting EPAC1
$1,209,563Xiaodong Cheng · University Of Texas Hlth Sci Ctr Houston · R01 · FY2017 · AI
Inflammatory Bowel Disease Genetics Consortium Data Coordinating Center
$1,209,523Judy H Cho · Icahn School Of Medicine At Mount Sinai · U01 · FY2013 · DK
Mechanism of action and therapeutic utility of immunostimulatory CpG oligonucleo
$1,209,238Dennis Klinman · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Viral And Cellular Factors Governing Efficient Gene Delivery
$1,209,233Maribeth V. Eiden · National Institute Of Mental Health · ZIA · FY2012 · MH
University of Iowa Hawkeye Intellectual and Developmental Disabilities Research Center (Hawk-IDDRC)
$1,208,922Lane Strathearn · University Of Iowa · P50 · FY2022 · HD